The Joint Research Centre develops methods to produce radionuclides for medicine and supports the Member States to advance activities to connect and unleash the potential of nuclear applications in medicine. For example, research on Alpha-emitters based therapy for prostate cancer.

The Council conclusion urges the Commission to:

• maintain Europe’s global leadership role in the supply of medical radioisotopes;
• monitor and forecast demand and supply for all relevant medical radioisotopes;
• support research and innovation, together with the Member States and benefiting [...] from the expertise and infrastructures of the Joint Research Centre (JRC), on topics related to medical radioisotopes and other medical radiological technologies;
• foster assessment and development of critical skills for safe and secure production and use;
• assess of the framework for transporting radioisotopes for medical use.

Press release of the Council of the EU